Gonorrhea Testing: What to Know About Screening, Methods, and Results
Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. Because many infections produce no symptoms, testing is the only reliable way to know whether someone has it. This guide explains how gonorrhea testing is performed, who should consider it, and what results mean.
Key takeaways
- Gonorrhea testing detects the bacterium Neisseria gonorrhoeae, often using nucleic acid amplification tests (NAATs) on urine or swab samples.
- Many gonorrhea infections cause no symptoms, so routine screening is important for people at higher risk.
- The CDC recommends annual screening for sexually active women under 25 and for older women with risk factors, as well as for men who have sex with men.
- A positive result is treatable with antibiotics, but repeat testing may be advised because of reinfection risk and antibiotic resistance.
What Gonorrhea Testing Detects
Gonorrhea testing looks for evidence of the bacterium Neisseria gonorrhoeae in a sample taken from the body. The most common laboratory method is nucleic acid amplification testing, or NAAT, which identifies genetic material from the bacterium. NAATs are highly sensitive and can detect infection from urine or from swabs of the urethra, cervix, vagina, rectum, or throat.
Testing is different from diagnosis based on symptoms alone. Because gonorrhea can infect the throat and rectum without causing noticeable signs, laboratory testing is needed to confirm the infection and guide treatment. A clinician selects the sample type based on the person's anatomy and possible exposure sites.
Who Should Get Tested and How Often
Screening recommendations focus on people at higher risk of infection. The Centers for Disease Control and Prevention recommends annual gonorrhea screening for sexually active women younger than 25 years and for older women with risk factors such as a new sex partner, more than one sex partner, a partner with an STI, or inconsistent condom use. Annual screening is also recommended for sexually active men who have sex with men at sites of exposure.
Pregnant women are often screened for gonorrhea because infection can affect pregnancy outcomes and can be passed to a newborn during delivery. Anyone who has symptoms suggesting an STI, or who learns a partner has gonorrhea, should be tested. A clinician can help determine the right testing interval based on individual circumstances.
Sample Collection Methods
Sample collection depends on the testing method and the sites that may be infected. A first-catch urine sample is commonly used for NAAT testing in people with a urethra. For other sites, a clinician may collect a swab from the cervix, vagina, urethra, rectum, or throat. Some clinics offer self-collected swabs for certain sites, which can make testing more comfortable.
In some situations, a culture may be used instead of or in addition to NAAT. Culture involves growing the bacterium from a sample and can provide information about antibiotic susceptibility, which is useful when resistance is a concern. Culture is also sometimes used for medicolegal purposes. A healthcare provider decides which method is appropriate.
Understanding Results and Next Steps
A positive gonorrhea test means the bacterium was detected and treatment is needed. Gonorrhea is treatable with antibiotics, and current guidance from the CDC recommends a single intramuscular dose of ceftriaxone for uncomplicated gonorrhea. Treatment should be prescribed by a clinician, and sexual partners should be evaluated and treated to prevent reinfection and further transmission.
A negative result generally means no infection was detected, but timing matters. Testing too soon after exposure can miss an infection because it takes time for the bacterium to reach detectable levels. Repeat testing may be recommended after treatment in certain cases, and people should avoid sex until they and their partners have completed treatment and symptoms have resolved. Antibiotic resistance in gonorrhea is an ongoing concern, which is why laboratory confirmation and appropriate treatment matter.
Frequently Asked Questions
how to test for gonorrhea
Gonorrhea is usually tested with a nucleic acid amplification test (NAAT) on a first-catch urine sample or a swab from the cervix, vagina, urethra, rectum, or throat. A clinician chooses the sample sites based on possible exposure. In some cases, a culture may be used, especially when antibiotic susceptibility information is needed.
How long after exposure should I get tested for gonorrhea?
The window period can vary, but many guidelines suggest waiting about one to two weeks after a possible exposure before testing, because it can take time for an infection to become detectable. A healthcare provider can advise on the best timing for an individual situation.
Can gonorrhea be detected without symptoms?
Yes. Many gonorrhea infections cause no symptoms, particularly in the throat and rectum. That is why routine screening is recommended for people at higher risk, even when they feel well.
Is gonorrhea curable?
Gonorrhea can be cured with antibiotics. The CDC currently recommends ceftriaxone for uncomplicated gonorrhea. Treatment must be prescribed by a clinician, and partners should also be evaluated and treated to prevent reinfection.
Sources
Ready to get tested? Examine the included markers, read the collection notes, and reserve the panel with the STDTestingBooking partner today.
Order Chlamydia & Gonorrhea Urine Test | STD TestReviewed by the STDTestingBooking Editorial Team
Each STD panel is reviewed by the STDTestingBooking editorial desk against authoritative reference data.